Pityriasis Lichenoides Chronica

  • Paloma BorregónEmail author
  • Agustín España


Pityriasis lichenoides (PL) is an uncommon, acquired skin condition. It represents a unique group of inflammatory skin disorders that include pityriasis lichenoides et varioliformis acuta (PLEVA or Mucha-Habermann disease) and pityriasis lichenoides chronica (PLC). PLEVA and PLC are two ends of a disease spectrum. Topical corticosteroids, phototherapy and oral tetracycline or erythromycin are the most recommended treatments for pityriasis liichenoides chornica.


Pityriasis lichenoides Juliusberg Lymphomatoid papulosis Parapsoriasis T-cell lymphoproliferative disorder 

Further Reading

  1. Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006;55:557–72.CrossRefGoogle Scholar
  2. Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment. Am J Clin Dermatol. 2007;8:29–36.CrossRefGoogle Scholar
  3. López-Villaescusa MT, Hernández-Martín A, Colmenero I, Torrelo A. Pityriasis lichenoides in a 9-month-old boy. Actas Dermosifiliogr. 2013;104:829–30.CrossRefGoogle Scholar
  4. Simon D, Boudny C, Nievergelt H, Simon HU, Braathen LR. Successful treatment of pityriasis lichenoides with topical tacrolimus. Br J Dermatol. 2004;150:1033–5.CrossRefGoogle Scholar
  5. Wood GS, Reizner G. Other papulosquamous disorders. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. 2nd ed. Spain. Mosby Elsevier; 2008. p. 139–41.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of DermatologyClínica Universidad de NavarraMadridSpain
  2. 2.Department of DermatologyUniversity Clinic of Navarra, School of MedicinePamplonaSpain

Personalised recommendations